All Companies

CORCongressional Stock Trades

Cencora, Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries

Congressional stock trades in Cencora, Inc. (COR) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

6

Politicians Trading

5

Last Traded

May 15, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Alan ArmstrongRJul 21, 2026Mar 27, 2026Buy$1,001 - $15,000+8.98%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$50,001 - $100,000+22.31%

Price History

About Cencora, Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

FAQ

5 members of Congress have disclosed 6 trades in Cencora, Inc. (COR). Most active: Jared Moskowitz (2), Alan Armstrong (1), Greg Landsman (1).

Across all disclosures, members of Congress reported 2 purchases and 4 sales of Cencora, Inc. (COR). The most recent trade was on May 15, 2026.

Ro Khanna disclosed buying Cencora, Inc. (COR) on May 15, 2026, valued at $1,001 - $15,000.

Jared Moskowitz disclosed selling Cencora, Inc. (COR) on May 6, 2026, valued at $1,001 - $15,000.

From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.